Lobbyist information

Amount

Dean Richlin	$0.00
Employed Terminated 01/01/2018

Kevin C. Conroy	$76,000.00
Employed Terminated 01/01/2018 12/18/2018

Martha Coakley	$0.00
Employed Terminated 01/01/2018

Pat Cerundolo	$104,021.42
Employed Terminated 01/01/2018

Total salaries paid:      $180,021.42

Client information

Amount

Amgen Inc.

$0.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Legislation, regulations, and issues related to pharmaceuticals, biotechnology, and health care, including but not limited to biosimilars, corporate taxation, state exchanges, pharmaceutical transparency and price controls, healthcare payment reform, pharmaceutical co-pay assistance, general patient access issues, and Medicaid.

bluebird bio	$8,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 11/27/2018 Area of Interest: State Medicaid coverage and payment policies for gene therapies.

Brookfield Power US Asset Management LLC	$36,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/02/2018 Areas pertaining to clean energy policies and regulation pursued by executive agencies such as the Executive Office of Energy and Environmental Affairs, the Department of Energy Resources, the Department of Environmental Protection and others.

Dicerna Pharmaceuticals, Inc.

$0.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 07/06/2018 Biotechnology-related. Currently, there are multiple bills pending and discussions/hearings being had that relate to the handling of trade secrets - their protection and remedies when they have been misappropriated. We are providing comment generally on this legislation. The JOINT COMMITTEE ON LABOR AND WORKFORCE DEVELOPMENT has held recent hearings on this subject.

DraftKings Inc.	$0.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Regulation of fantasy sports

Gilead Sciences, Inc.	$0.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Any and all matters relating to Gilead Sciences, Inc. including HIV/AIDS, Hepatitis C, drug price transparency, patient access to health care, including bills S.652, S.627, H.3223, and H.2983.

Guardian Community Trust, Inc.

$0.00

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Dean Richlin, Esq., of Foley Hoag, LLP, has been retained to help us interact with the Massachusetts Executive Office of Health and Human Services, regarding MassHealth regulations that affect the operations of the pooled special needs trust program that our organization manages. He is advising us about strategy and attending meetings to help us to communicate effectively with the Office. This will be a relatively limited engagement, focusing upon a current, specific proposed regulation change, which we hope will be completed in early 2018.

Massachusetts Biotechnology Council

$96,085.29

Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 Implementation of Chapter 224 the Acts of 2012; drug recycling and disposal policies; provider and industry practices related to pharmaceuticals, including drug pricing, drug price transparency; prescribing, dispensing and monitoring controlled substances and related policies; patient access and prescribing related policies; registration of drug product manufacturers.

NRG Energy	$40,000.00
Employed Terminated Details about your lobbyist or lobbyist entity's efforts 01/01/2018 09/30/2018 Legislative and Executive Branch legislation, rules and regulations affecting the electric power industry, including but not limited to electric generation, solar, wind, distributed energy resources, electric vehicle charging, electric retail, and environmental issues.

Total salaries received:      $180,085.29

Expenditures

Amount